An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...
Brookhaven National Laboratory have developed a novel artificial intelligence (AI)-based method to dramatically tame the ...
@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...
1d
Pioneering Reliability and Precision: The Rise of Top Environmental Testing Equipment Manufacturers
XIAN HIGH-TECH AREA, SHAANXI, CHINA, January 19, 2026 /EINPresswire.com/ -- With increasing demands for product ...
Researchers at UCL and Great Ormond Street Hospital (GOSH) have developed the first-ever lab-grown mini-stomach that contains ...
While labs overwhelmingly welcomed the ruling, it could make it more difficult for firms that want FDA's imprimatur for LDTs ...
Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...
NEW YORK – Results of a clinical trial of over 5,000 women showed that Sera Prognostics' PreTRM liquid biopsy paired with targeted treatments reduced the risk of preterm births and improved outcomes ...
A growing body of research underscores the value of ctDNA-based MRD testing to identify residual or recurring cancer in solid tumors. By detecting trace amounts of tumor-derived DNA in the bloodstream ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian site GraftAssureDx™ FDA IVD approval application 95% complete at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results